Off-Label Use and Dosage (Pediatric) Guideline-Supported Use There is limited information regarding Off-Label Guideline-Supported Use of Levocarnitine (injection) in pediatric patients
Randomized controlled trials before the issue of CVOTs by the FDA in 2008 mainly focused on the efficacy of the blood glucose-lowering effects and a broad spectrum of adverse effects, with limited numbers of cardiovascular adverse events and relatively short follow-up duration
Annu Rev Nutr (2017) 37:15781
Early biomarker response and patient preferences to oral and intramuscular vitamin B12 substitution in primary care: a randomised parallel-group trial
They have participated in studies on: Intellectual and neurological development and behaviour in children The adverse effects of toxic waste and heavy industrialisation on hypertension, cardiovascular disease and other conditions The biochemical connection between aberrant behaviour and violence in juveniles and adults Zinc deficiency and suppression of growth in humans They have partnered with Argonne National Laboratory, Brookhaven National Laboratory, Johns Hopkins Hospital, the European Commission Joint Research Centre, the United States Navy, the California Criminal Justice System, the Oklahoma Department of Health and Human Services, and the universities of California, Florida, Illinois, and Texas, among others
